Biohit Group Half Year Financial Report 2021
Biohit Oyj Half Year Financial Report 11 August 2021 at 9:30 am local time (EET) SUMMARY January-June 2021 ·Revenue EUR 4.0 million (EUR 3.0 million) · Revenue increased by 36% compared to H1/2020 · Operative EBITDA EUR -0.2 million (EUR -1.0 million) · Cash at the end of the period EUR 1.0 million (EUR 1.0 million 31 December 2020) · Fair value of Genetic Analysis AS investment EUR 0.8 million (EUR 0.8 million 31 December 2020) · Revenue from international operations 97.2% (95.6%) of total revenue · Equity ratio 78.4% (80.8% 31 December 2020) BIOHIT